Accordingly, genetic ablation of one of the key factors of the accessory TTFL, REV-ERBα, leads to increased susceptibility to experimental colitis in mice, whereas mice with increased REV-ERBα activation are protected (61). The gene discussed is NR1D1; the disease is colitis.